QA: Sierra Oncology Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001290149_2021_Sierra_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('stock_price')"}

Graph

Absolute values for 0001290149, Sierra Oncology Inc.

  xvar xval
0 AssetsCurrent 106,470,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 52,000
3 remainder_Assets 965,000
4 LiabilitiesCurrent 9,353,000
5 LiabilitiesNoncurrent 175,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,123,000
9 ResearchAndDevelopmentExpense 45,118,000
10 remainder_Expenses 142,000
11 remainder_Revenues 300,000
12 remainder_NetIncome -15,819,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 107,487,000
1 Liabilities 9,528,000
2 Expenses 65,383,000
3 Revenues 300,000
4 StockholdersEquity 97,959,000
5 NetIncome -80,902,000
6 ComprehensiveNetIncome -80,902,000
7 BaseVar 99,258,500
8 EconomicCapitalRatio 1.50

Edgar->Model Mapping

Feature Distribution

Change over Time